Clinical Trial Update: Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating selinexor with R-CHOP followed by selinexor maintenance for untreated EBV-positive diffuse large B-cell lymphoma. Status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-CHOP
• Selinexor (selinexor)

Snippet

Sponsor: Sun Yat-sen University | Conditions: EBV-Positive Diffuse Large B-Cell Lymphoma, Nos | Phase 1, Phase 2 | Status: UNKNOWN